US Markets
AZN

Peru rejects AstraZeneca coronavirus vaccine purchase deal

Credit: REUTERS/STEFAN WERMUTH

The Peruvian government said on Thursday that it refused to sign a coronavirus vaccine purchase agreement with AstraZeneca PLC because it did not provide sufficient data from its studies and offered minimal amounts of inoculations.

LIMA, Oct 22 (Reuters) - The Peruvian government said on Thursday that it refused to sign a coronavirus vaccine purchase agreement with AstraZeneca PLC AZN.L because it did not provide sufficient data from its studies and offered minimal amounts of inoculations.

Prime Minister Walter Martos said in a news conference that the government had asked AstraZeneca for data from its vaccine studies, but that the firm had not sent the information.

"The other labs have caught up with us accordingly, however AstraZeneca has not," Martos said.

"They were offering us a very low quantity of vaccines compared with other laboratories that are offering us large quantities at lower costs," he said.

Brazil said Wednesday that a volunteer died in a clinical trial of the COVID-19 vaccine developed by AstraZeneca and the University of Oxford, but added that laboratory testing would continue.

Despite a slowdown in the number of new infections in Peru, a second wave of the pandemic in the country is possible, Martos said. AstraZeneca planned to conduct trials in Peru.

The rate of infections and deaths from COVID-19 in Peru has been slowing since September. As of Tuesday, COVID-19 cases in Peru totaled 876,885, with 33,937 deaths.

(Reporting by Marco Aquino; Writing Hugh Bronstein; Editing by Christopher Cushing)

((hugh.bronstein@thomsonreuters.com; 5411 4318 0655; Reuters Messaging: hugh.bronstein.thomsonreuters.com@reuters.net))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

AZN

Latest Markets Videos

    Reuters

    Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

    Learn More